#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Gaucher's disease type III Epilepsy with myoclonic-atonic seizures Amyotrophic lateral sclerosis Retinopathy proliferative Alveolar rhabdomyosarcoma Chronic myeloid leukaemia (in remission) VEXAS syndrome Non-Hodgkin's lymphoma refractory Arrhythmia Lymphangioma Marginal zone lymphoma Ornithine transcarbamoylase deficiency Gastrooesophageal cancer Glioma More trials…

    Learn about Rare Diseases

    Pemphigus – Treatment Basal cell naevus syndrome – Basic Information Hairy cell leukaemia Leiomyosarcoma Adrenogenital syndrome – Life with Disease Fragile X syndrome – Trials in Disease Lymphatic malformation – Trials in Disease Advanced systemic mastocytosis – Diagnostics Leukoencephalopathy – Treatment Niemann-Pick disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aspartic Acid Carbasalate Calcium Ataluren Levofloxacin Iobitridol Canis Familiaris (553) Dextrose Bp Human Apotransferrin Bendamustine Hydrochloride Nimotuzumab Imetelstat Sodium Efanesoctocog Alfa Pyridoxine Rilpivirine Hydrochloride Nandrolone Decanoate Pomalidomide Itacitinib ANTI-GD2-800CW Olodaterol Phleum Pratense (225) More therapies…

    Learn about Your Condition

    Leukaemia Acute hepatic failure Vesicoureteric reflux Fallopian tube cancer stage IV Cardiac ventricular thrombosis Aortic valve disease Endocarditis Adrenoleukodystrophy Graves' disease Triple negative breast cancer Primary adrenal insufficiency Kawasaki's disease Sexual dysfunction Proteinuria Systemic infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of GAL-101 Eye Drops for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Recruiting

    2 1
    Investigated Drugs:
    • SODIUM (R)-2-(2-AMINO-3-(1H-INDOL-3- YL)PROPANAMIDO)-2-METHYLPROPANOATE-PROPAN-2-OL
    France Germany Ireland Italy

  • Study on Obinutuzumab for Patients with Relapsing Granulomatosis with Polyangiitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Obinutuzumab
    France

  • Study of Elritercept for Treating Anemia in Adults with Low to Intermediate Risk Myelodysplastic Syndromes

    Recruiting

    3 1
    Investigated Drugs:
    • Elritercept
    Bulgaria Czechia France Germany Hungary Ireland +5

  • Study on the Effectiveness of Green Tea Extract and Trichloroacetic Acid for Treating Anal High-Grade Squamous Intraepithelial Lesions in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervical dysplasia
    Investigated Drugs:
    • Camellia Sinensis (Green Tea) Leaf Extract
    Spain

  • Study on Inclisiran, Alirocumab, and Rosuvastatin for Children with Familial Hypercholesterolemia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Alirocumab
    • Inclisiran
    • Rosuvastatin
    Poland

  • Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • NADOFARAGENE FIRADENOVEC
    Czechia Denmark France Italy Poland Spain
Previous Page
1 … 236 237 238 239 240 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!